Relationship Among Vaginal Palpation, Vaginal Squeeze Pressure and Dynamometry of Nulliparous Pelvic Floor Muscles
NCT ID: NCT02831452
Last Updated: 2016-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
141 participants
OBSERVATIONAL
2014-12-31
2015-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Pelvic Floor Muscles Strength and Sexual Function in Primigravid and Non-pregnant Nulliparous
NCT02866292
Can Women Correctly Contract Their Pelvic Floor Muscles After to Receive Verbal Instructions and Vaginal Palpation?
NCT03325543
Effects of Visceral Manipulation in Women With Urinary Incontinence
NCT03945578
Pelvic Floor Muscle Function in Nulliparous and Primiparous.
NCT01315769
A Randomized Controlled Trial Comparing the Effect of Pelvic Floor Muscle Training
NCT01794910
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Assessments began after explaining how to perform the PFM contraction. The vaginal palpation was always the first exam to check the PFM contraction ability and then the order of vaginal squeeze pressure exam and dynamometry was randomized.
The PFM assessment by digital palpation was performed as proposed by Laycock and Jerwood. The physiotherapist introduced the index and middle fingers about 4 cm inside the vagina, and requested to hold the maximum contraction of the PFM, according to the instruction of a movement "inward and up" with the greatest possible strength. Muscle function was classified by the Oxford Scale Modified, which varies from zero (absence of muscle contraction) to five (strong contraction). The vaginal squeeze pressure was measured through Peritron equipment (Cardio Design Pty Ltd, Oakleigh, Victoria, Australia) equipped with a vaginal probe that has been covered with a non-lubricated condom and then the probe was lubricated with hypoallergenic gel. The probe sensor was connected to a microprocessor hand with a latex tube, which allows the measurement of nip pressure in centimeters of water (cmH2O). To obtain the measurements, the subjects remained positioning and vaginal sensor was introduced approximately 3.5cm into the vaginal cavity. Then the device was inflated to 100cmH2O (calibration). The female volunteers were oriented and motivated verbally to perform three voluntary maximal contractions sustained for five seconds and one minute interval between them. The correct contraction was checked visually by the physiotherapist. All volunteers were instructed to avoid using the abdominal muscles, gluteal and hip adductor. For statistical analysis, the investigator used the peak pressure provided by the equipment. The PFM contraction strength was assessed by vaginal dynamometer EMG System do Brasil (model DFV 020.101/10). It is cylindrical in shape (9.5 cm in length and 3.3 cm in diameter), made of steel and is equipped with a load cell 2 cm from its base, which can measure anteroposterior unidirectional compressive strength in Kg/force (Kgf). The equipment was previously coated with a condom and lubricated with hypoallergenic gel, which was inserted into the vaginal cavity with the load cell positioned so that it could capture the anteroposterior compression strength. The participant was asked to perform three maximal voluntary PFM contractions for eight seconds with a rest period of 30 seconds between the contractions. The same precautions for correct contraction were adopted. The best value of maximum strength (difference between the highest and lowest strength in Kgf) was used for statistical analysis. Statistical analysis was performed using Statistical Package for Social Sciences software (SPSSV17, Chicago, IL). Data normality was tested by the Shapiro-Wilk test.
To verify the correlation between the variables, the Pearson correlation test was used. Values of p \< 0.05 were considered significant. The correlation values were interpreted according to the following guidelines: 0.00 - 0.19= no to slight; 0.20-0.39= mild; 0.40-0.69= moderate; 0.70-0.89= high and 0.90-1.00= very high. Data were expressed as mean and standard deviation (SD).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-pregnant nulliparous
nulliparous without previous gestation. Pelvic floor muscle evaluation by means of vaginal palpation, vaginal squeeze pressure (perineometer), and pelvic floor muscle strength using a proper vaginal dynamometer.
pelvic floor muscle strength evaluation
primigravid on 1º trimester
nulliparous women on her first pregnancy and gestational age until 13 weeks and 6 days.
Pelvic floor muscle evaluation by means of vaginal palpation, vaginal squeeze pressure (perineometer), and pelvic floor muscle strength using a proper vaginal dynamometer.
pelvic floor muscle strength evaluation
primigravid on 2º trimester
nulliparous women on her first pregnancy and gestational age between 14 weeks and 27 weeks.
Pelvic floor muscle evaluation by means of vaginal palpation, vaginal squeeze pressure (perineometer), and pelvic floor muscle strength using a proper vaginal dynamometer.
pelvic floor muscle strength evaluation
primigravid on 3º trimester
nulliparous women on her first pregnancy and gestational age above 28 weeks. Pelvic floor muscle evaluation by means of vaginal palpation, vaginal squeeze pressure (perineometer), and pelvic floor muscle strength using a proper vaginal dynamometer.
pelvic floor muscle strength evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pelvic floor muscle strength evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to contract correctly the PFM
* without urogynecological complaints
Exclusion Criteria
* without previous sexual intercourse
* present neuromuscular diseases
16 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ana Paula Magalhães Resende
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Uberlândia
Uberlândia, Minas Gerais, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1061162/2014 CEP/UFU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.